Y. Hirao

The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer Is there a benefit for survival or preserving the bladder?

W. Shipley, N. Miyanaga, S. Kamidono, 1998, Urologic oncology.

Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers.

E. Okajima, Y. Konishi, M. Tsutsumi, 1996, Cancer letters.

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer

C. Marsit, M. Karagas, A. Schned, 2005, Cancer.